Investor news from FierceBiotech
NewsSPOTLIGHT: Silver lining to Big Pharma's cloud?
Some people see the Big Pharma glass as half-full instead of the alternative. In an investor's-eye look at the industry, Kiplinger ticks off the usual criticisms: patent expirations, tough generics... Read more...
Report: Wilex, GPC nearing merger pact
Two German biotech companies which share a very big investor are preparing to merge, according to a prominent German newspaper. Wilex and GPC Biotech, both involved in developing new cancer... Read more...
PDL axes 260 and takes itself off the market
With no "firm" buyout offers coming in, PDL BioPharma has decided to axe 260 workers--on top of the 320... Read more...
Memory's CEO steps down
Memory Pharmaceuticals' CEO Jim Sulat has announced plans to step down from the position for personal reasons. He will remain the company's part-time CFO. Taking his place for the time being is... Read more...
PDL sells off drugs as it counters harsh criticism
PDL BioPharma has auctioned off two marketed drugs and two experimental therapies as it restructures in the face of some severe criticism over how it's been managed. PDL was
PeptImmune land $8.2M in series D
Cambridge, MA-based PeptImmune has garnered $8.2 million in a fourth round of funding. New Enterprise Associates, MPM Capital, Hunt Ventures L.P., Boston Medical Investors and Silicon Valley Bank... Read more...
Reader feedback: FDA approvable letters and China outsourcing
Jim Davis at Sagient Research Systems wanted to follow up yesterday's piece on the trend at the FDA regarding
Is Carl Icahn out to buy Genzyme?
Rebel investor Carl Icahn (photo) has bought a stake in Genzyme, spurring speculation that he may be preparing to give it the kind of
AdvanDX finds $15M in third VC round
France's BioMerieux has signed on as an investor for AdvanDX, a diagnostics company based in Woburn, MA, contributing to a $15 million Series C round for the company. The money is earmarked for... Read more...
In last act, PDL chief takes out the axe
Mark McDade has already announced that he's leaving his post as CEO of PDL BioPharma at the end of the year. And last night he... Read more...
| Press ReleasesPRESS RELEASE: Accelerator Corporation Raises Third Round of Committed Capital, Adds Additional InvestorAccelerator Corporation Raises Third Round of Committed Capital, Adds Additional Investor WRF Capital Joins Other Life Science Leaders to Fund Biotech Start Ups SEATTLE, Aug. 3 -- Accelerator Read more >> |
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
